Xiaoqing Dai
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
CRISPR-based genome editing in primary human pancreatic islet cells.
Journal: Nature communications
Published: October 13, 2020
Improved glucose tolerance with DPPIV inhibition requires β-cell SENP1 amplification of glucose-stimulated insulin secretion.
Journal: Physiological reports
Published: February 05, 2020
Interleukin-1 signaling contributes to acute islet compensation.
Journal: JCI insight
Published: October 05, 2016
Kv2.1 Clustering Contributes to Insulin Exocytosis and Rescues Human β-Cell Dysfunction.
Journal: Diabetes
Published: September 26, 2016
SUMOylation and calcium control syntaxin-1A and secretagogin sequestration by tomosyn to regulate insulin exocytosis in human ß cells.
Journal: Scientific reports
Published: September 16, 2016
Converting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx.
Journal: Cell metabolism
Published: June 16, 2016
Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors.
Journal: PLoS genetics
Published: June 05, 2015
Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism.
Journal: Cell reports
Published: May 11, 2015
Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells.
Journal: The Journal of clinical investigation
Published: April 23, 2015
DeSUMOylation Controls Insulin Exocytosis in Response to Metabolic Signals.
Journal: Biomolecules
Published: January 01, 2012
Last Updated: 09/26/2026